Hyogo, Japan

Kunihiko Dohtsu


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,891 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Kunihiko Dohtsu

Introduction: Kunihiko Dohtsu, an esteemed inventor from Hyogo, Japan, has made significant contributions to the field of pharmaceuticals through his innovative work on a unique compound. His single patent addresses the crucial need for effective hypoglycemic agents and PDE5 inhibitors, marking a vital step in medical advancements.

Latest Patents: Kunihiko Dohtsu holds a patent for "Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide." This compound exhibits notable hypoglycemic activity and PDE5 inhibitory effects. The patent describes three distinct crystal forms of this compound, each characterized by unique X-ray powder diffraction values. Among these, the most crystallographically stable form proves to be exceptionally useful as a drug substance in medicine. Another form presents advantages in purification processes, yielding larger crystals that can be easily isolated through filtration.

Career Highlights: Throughout his career, Kunihiko Dohtsu has demonstrated a focus on producing compounds that address pressing health concerns. His innovative spirit and dedication have led to breakthroughs that not only enhance drug formulation but also improve the lives of individuals requiring medical treatment for diabetes and related conditions.

Collaborations: Teamwork has been pivotal in Kunihiko’s journey as an inventor. He has collaborated with talented colleagues such as Yoshiyuki Murai and Noritsugu Yamasaki, enhancing the innovation process and expanding the potential for future discoveries.

Conclusion: Kunihiko Dohtsu exemplifies the role of inventors in advancing healthcare through innovative compounds and formulations. His patented work on the crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3H-benzimidazole-5-carboxamide reflects a deep commitment to improving therapeutic options available for patients. As the landscape of pharmaceutical invention continues to evolve, the contributions of dedicated inventors like Kunihiko remain vital.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…